BofA lowered the firm’s price target on RXO Inc. (RXO) to $16 from $18 and keeps a Neutral rating on the shares after the company reported Q3 results and issued a Q4 EBITDA target significantly below BofA and the Street’s forecast. Following the report and guidance, the firm lowered its FY26 and FY27 EPS estimates by 61% and 39%, respectively.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: